Association ofp53codon 72 polymorphism andMDM2SNP309 with clinical outcome of advanced nonsmall cell lung cancer
作者： Ji-Youn Han , Geon Kook Lee , Dae Ho Jang , Sung Young Lee , Jin Soo Lee
DOI: 10.1002/CNCR.23668
关键词:
摘要: … MDM2 SNP309 may modulate p53 function, we hypothesized that treatment outcomes of nonsmall cell lung … Generally, simultaneous p53 mutation and MDM2 amplification do not occur …
sci-hub.se 参考文章(49)
George Dl, Landers Je, Haines Ds, Strauss Jf rd, Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene. ,vol. 9, pp. 2745- 2750 ,(1994)
Steven A Ahrendt, John T Chow, Stephen C Yang, Li Wu, Mei Jie Zhang, Jin Jen, David Sidransky, None, Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Research. ,vol. 60, pp. 3155- 3159 ,(2000)
Bert Vogelstein, David Lane, Arnold J. Levine, Surfing the p53 network Nature. ,vol. 408, pp. 307- 310 ,(2000) , 10.1038/35042675
J S Lee, A Yoon, S K Kalapurakal, J Y Ro, J J Lee, N Tu, W N Hittelman, W K Hong, Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor. Journal of Clinical Oncology. ,vol. 13, pp. 1893- 1903 ,(1995) , 10.1200/JCO.1995.13.8.1893
Takashi Tokino, Takashi Tokino, Bert Vogelstein, Kenneth W. Kinzler, David Sidransky, David E. Hill, Jonathan D. Oliner, Sharon Smith, Marilee Burrell, Fredrick S. Leach, Paul Meltzer, p53 Mutation and MDM2 Amplification in Human Soft Tissue Sarcomas Cancer Research. ,vol. 53, pp. 2231- 2234 ,(1993)
Joan H. Schiller, Sudeshna Adak, Richard H. Feins, Steven M. Keller, Willard A. Fry, Robert B. Livingston, M. Elizabeth M. Hammond, Barbara Wolf, Linda Sabatini, James Jett, Leslie Kohman, David H. Johnson, Lack of Prognostic Significance of p53 and K-ras Mutations in Primary Resected Non–Small-Cell Lung Cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy Journal of Clinical Oncology. ,vol. 19, pp. 448- 457 ,(2001) , 10.1200/JCO.2001.19.2.448
Arnold J. Levine, Shengkan Jin, The p53 functional circuit. Journal of Cell Science. ,vol. 114, pp. 4139- 4140 ,(2001) , 10.1242/JCS.114.23.4139
Jonathan D. Oliner, Jennifer A. Pietenpol, Sam Thiagalingam, Jeno Gyuris, Kenneth W. Kinzler, Bert Vogelstein, Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 Nature. ,vol. 362, pp. 857- 860 ,(1993) , 10.1038/362857A0
T Kondo, T Tanita, Y Matsumura, Y Saito, M Sagawa, H Aikawa, M Sato, S Fujimura, H Takahashi, C Endo, A Sakurada, Y Chen, MDM2 expression is associated with progress of disease and WAF1 expression in resected lung cancer. International Journal of Molecular Medicine. ,vol. 5, pp. 631- 633 ,(2000) , 10.3892/IJMM.5.6.631
Gareth L. Bond, Wenwei Hu, Arnold Levine, A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect. Cancer Research. ,vol. 65, pp. 5481- 5484 ,(2005) , 10.1158/0008-5472.CAN-05-0825